FORA Capital’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,385
Closed -$208K 529
2022
Q4
$208K Buy
+1,385
New +$213K 0.03% 438
2022
Q2
Sell
-15,737
Closed -$2.75M 442
2022
Q1
$2.75M Buy
15,737
+8,650
+122% +$1.45M 0.5% 52
2021
Q4
$1.83M Sell
7,087
-3,988
-36% -$1.09M 0.71% 28
2021
Q3
$3.02M Buy
11,075
+7,461
+206% +$2.37M 0.76% 35
2021
Q2
$809K Buy
3,614
+2,535
+235% +$478K 0.15% 175
2021
Q1
$118K Sell
1,079
-11,269
-91% -$1.2M 0.04% 381
2020
Q4
$1.01M Buy
+12,348
New +$1.21M 0.15% 152
2020
Q3
Sell
-4,472
Closed -$298K 677
2020
Q2
$298K Buy
+4,472
New +$223K 0.1% 253

Other funds holding BNTX

FORA Capital's BNTX Position: Q1 2023 in Review

FORA Capital sold out of BioNTech (BNTX) in Q1 2023, closing a stake of 1,385 shares — an estimated $208K sold.

FORA Capital first reported a position in BNTX in Q2 2020 and held it in 8 quarters. The position peaked at $3.02M in Q3 2021. 282 funds tracked by Wall St. Rank hold BNTX as of Q1 2023.

  • FORA Capital reported no remaining BioNTech position as of Q1 2023 after selling out during the quarter.
  • FORA Capital sold 1,385 BioNTech shares in Q1 2023, an estimated $208K.
  • FORA Capital first reported a position in BioNTech in Q2 2020 and held it in 8 quarters.
  • FORA Capital's BioNTech position peaked at $3.02M in Q3 2021.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q1 2023.

Based on FORA Capital's 13F filing for Q1 2023, filed 12 May 2023.